Bloomberg Law
July 16, 2020, 5:32 PMUpdated: July 16, 2020, 9:16 PM

Bayer Misled Investors on Monsanto Deal Roundup Risk: Suit (1)

Jennifer Bennett
Legal Reporter

Bayer AG didn’t warn investors about the potential risk of billion-dollar judgments and reputation damage when it acquired Roundup maker Monsanto Co., a would-be class suit said in California federal district court.

The pharmaceutical and life sciences firm “specifically downplayed” liability risks related to Roundup weed killer, which some consumers have blamed for their non-Hodgkin lymphoma, two pension plans said Wednesday in their U.S. District Court for the Northern District of California complaint.

“We are confident that we have always acted in accordance with our obligations under the applicable securities laws,” Chris Loder, a spokesperson for Bayer’s U.S. operations, told ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.